NFKB1 and acute lymphoblastic leukemia: By analyzing publicly available gene expression data from a cohort of 161 pediatric ALL patients [25], we confirmed the association between the overexpression of the NF-κB signaling pathway and WBC count after upfront in vivo MTX treatment, suggesting a link between the NF-κB pathway, drug resistance, and, ultimately, disease outcome.